| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ptc Therapeutics, Inc. (PTCT) has 18 insiders with recent SEC Form 4 filings, including 0 buys and 23 sells. PTCT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 394.1K | $27.66M | - | |
| Dir | 163.3K | $11.46M | - | |
| CFO | 90.3K | $6.34M | - | |
| Other | 80.1K | $5.63M | - | |
| VP | 79.1K | $5.55M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | Boulding Mark Elliott55 | Exec. VP And CLO | Sale+OE | 6,618 | $77.31 | $511,641.42 | -0.7% | -9.9% | - | |
| Jan 7, 2026 | Utter Christine Marie58 | SVP, Chief Accounting Officer | Sell | 2,616 | $77.19 | $201,918.70 | -1.7% | -9.9% | - | |
| Jan 7, 2026 | Pauwels Eric62 | Chief Business Officer | Sell | 3,141 | $77.18 | $242,416.51 | -1.8% | -9.9% | - | |
| Jan 7, 2026 | Klein Matthew B.54 | Chief Executive Officer | Sell | 8,165 | $77.15 | $629,895.23 | -1.0% | -9.9% | - | |
| Jan 7, 2026 | Golden Lee Scott | EVP &Chief Medical Officer | Sell | 1,982 | $77.12 | $152,855.16 | -1.0% | -9.9% | - | |
| Jan 6, 2026 | Gravier Pierre52 | Chief Financial Officer | Sell | 2,139 | $76.95 | $164,596.05 | -2.3% | -10.2% | - | |
| Jan 5, 2026 | Boulding Mark Elliott55 | Exec. VP And CLO | Sale+OE | 2,266 | $75.55 | $171,191.98 | -0.6% | -10.2% | - | |
| Jan 5, 2026 | Reeve Emma81 | Director | Sale+OE | 734 | $76.00 | $55,784.00 | -6.4% | -10.2% | - | |
| Jan 2, 2026 | Steele Glenn Jr Md Phd | Director | Sale+OE | 12,000 | $76.35 | $916,200.00 | -39.3% | -11.7% | - | |
| Dec 30, 2025 | Klein Matthew B.54 | Chief Executive Officer | Sell | 8,089 | $76.64 | $619,940.96 | -2.3% | -13.8% | - |